Although acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists exhibit efficacy for Alzheimer’s disease during the first year of treatment, they have not been shown to cure nor halt the progression of dementia in long-term follow-ups [2–4]. This evidence concerns the gene ACHE and dementia.